Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2025-01-20 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
2025 01 20 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between January 13 and January 17, 2025, including daily transaction tables. This activity directly relates to the company buying back or selling its own shares. According to the definitions, this corresponds precisely to the 'Transaction in Own Shares' category (Code: POS). The document is a detailed report of the transactions, not merely an announcement of a report's publication.
2025-01-20 Italian
2025 01 13 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. between January 6 and January 10, 2025, including daily transaction tables and total figures. This activity directly relates to the company managing its own stock capital. The filing category that specifically covers the report of the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). The document is a detailed report, not just an announcement of a report, so RPA/RNS is not the primary classification.
2025-01-13 Italian
Errata Corrige – Parziale Rettifica del Comunicato Stampa del 7 Gennaio 2025
Transaction in Own Shares Classification · 100% confidence The document is titled "PARZIALE RETTIFICA DEL COMUNICATO STAMPA DEL 7 GENNAIO 2025" (Partial Rectification of the Press Release of January 7, 2025). It discusses a correction regarding the number of treasury shares held by the company following a stock grant plan implementation. This action—the correction of shareholding data related to treasury stock management—falls directly under the category of transactions involving the company's own shares. The definition for 'Transaction in Own Shares' (POS) covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is a rectification of a previous communication, the core subject matter is the status of treasury shares, making POS the most specific fit over a general Regulatory Filing (RNS). The document length is short (3181 chars) and it is a specific update, not a comprehensive report.
2025-01-10 Italian
Allegato 3F
Transaction in Own Shares Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Model Disclosure for Transactions in the Issuer's Securities) and contains detailed tables outlining transactions (purchases 'A' and sales 'V') in the shares of PHILOGEN S.p.A. by another entity (MEDIOBANCA). This structure, focusing specifically on personal share transactions by directors, executives, or related parties (in this case, a major shareholder/entity involved in transactions), directly corresponds to the definition of Director's Dealing or Insider Trading reports. Reviewing the filing definitions, 'Director's Dealing (Code: DIRS)' is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. Although the reporting party here is MEDIOBANCA, the nature of the disclosure—a mandatory report detailing specific security transactions—fits the DIRS category better than general regulatory filings (RNS) or capital changes (SHA/POS), as it concerns insider/related party activity reporting. The reference to Annex 3F and the specific tabular format strongly suggests a regulatory filing related to insider transactions, aligning best with DIRS.
2025-01-07 Italian
2025 01 07 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between December 23, 2024, and January 3, 2025. It provides daily transaction summaries and detailed transaction logs. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category. Filing Code Check: - Not 10-K, AR, IR, ER, or MRQ (not a primary financial report). - It is specifically about share repurchase, matching 'POS' (Transaction in Own Shares). - It is not a general announcement of a report (RPA/RNS) because it contains the substantive data about the transaction itself, not just an announcement that the data exists elsewhere.
2025-01-07 Italian
The Board of Directors approves the launch of a share buyback program
Transaction in Own Shares Classification · 100% confidence The document is a press release announcing that the Board of Directors approved the launch of a share buyback program. It details the objectives, maximum number of shares, price limits, total value, and duration of the program, and names the broker appointed to execute it. This activity directly relates to the company's own shares being transacted in the market, which falls under the definition of 'Transaction in Own Shares'.
2024-12-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.